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Research Article Review
Submitted by Jean Beckel, RN, MPH

Article: Barr-Anderson, D., van den Berg, P., Neumark-Sztainer, D., Story, M. (2008).
Characteristics Associated with Older Adolescents Who Have a Television in Their
Bedrooms. Pediatrics. 121(4). 718-724.

As we approach the dark days of winter, there is increased temptation to
spend time in front of the TV. As a parent, I have had the “TV in the
bedroom” discussion with kids. The focus of this study, completed at the U of
MN, was to examine the prevalence of adolescents having a TV in their bedroom, and to describe the
associated personal, social, and behavioral characteristics. The literature review solidly documented
the TV-watching habits of the American teenager and indicated an association between the amount of
TV watching and poor school performance, poor dietary habits, and greater basal metabolic index. It
also found that youth who have a TV in the bedroom watch more hours per day of television. The
literature was lacking information related to the adolescent profiles for those having bedroom TVs.
Clinical Ladder

pg. 7

The researchers built on a prior research study which had tracked the behaviors and eating habits of
4,746 junior and senior high school students in 31 Minnesota schools. The new study involved 781 of
these students who met the age criteria for the new study. Participants completed a revised version of
the original study survey which asked about presence of a bedroom TV and their physical activity and
social behavior. 62% of the adolescents had a TV in their bedroom. Statistical analysis was used to
compare the teens with and without TVs in their bedroom. The presence of a TV was related to
gender, ethnicity and socio-economic status. Those with a bedroom TV also spent less time in vigorous
physical activity, eating fruits and vegetables, and having family meals together. There was also more
sedentary behavior and lower GPAs. There was no difference between snacking habits between
groups. Those with a TV also reported a much higher number of TV viewing hours.
Limitations of this study include the design where measurements were taken as a moment in time.
Researchers also relied on the accuracy of the adolescents’ self-reported responses to the study
questionnaire to make their conclusions. The strengths of the study include the large, ethnically
diverse study sample and the design of the survey tool. What are the conclusions?
•

As a parent: Many parents now work outside the home and have less control over the
number of hours their children watch TV. Parents do, however, make the decision on
whether or not a child can have a TV in their bedroom. Making a decision to refrain
from a bedroom TV may be the first step to decreasing “screen time” and the poor
behaviors associated with increased TV watching.

•

As a nurse: What aspects of our professional practice environment could be measured
and analyzed to result in better use of our time, space, and energy?

If you have ideas, please contact a member of the research committee. This group will guide you and
make the research process a practical and fun experience.
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Providing Care After Death – Important Steps to Follow:
Submitted by Barb Scheiber, Director, Patient Care Support

There are many steps to follow when a patient dies. The death checklist and policy, “Death, Care
Provided After” are resources for you. We continue to have some issues with Funeral Home Directors
arriving to pick up a body when donation status, autopsy, etc. are still pending. Please coordinate the
release of the body with the PPC/Administrative Nursing Supervisor for each death. Below are a few
reminders:
•

The death checklist serves as your guide. It follows in order of priority. For example, if a death is
unexpected or unexplained, you need to sequester equipment and have blood drawn as soon as
possible. Therefore, this item is listed at the top of the list.

•

The Administrative Nursing Supervisor/Patient Placement Coordinator must be notified of each
death. Include the name, time of death, medical record number, funeral home/location if known,
and any pending reasons for delaying the release of the body to the funeral home (example: ME
case, autopsy, organ/tissue/eye donation). Once everything has been completed, the
Administrative Nursing Supervisor/Patient Placement Coordinator notifies Admitting and authorizes
the release of the body to the funeral home. Admitting then calls the funeral
home to pick up the body.

•

Admitting should be called with the name, medical record number and time of
death as soon as possible. They maintain a log book of all deaths and are the
access point for funeral directors who pick up bodies. Funeral directors “sign
out” when they leave.

•

At times family members have told the funeral home that “everything is done.”
Unfortunately this can result in the funeral home director driving a distance only
to learn that some things are still pending (example: tissue donation). It would be helpful if you
could let family members know that the hospital (Admitting) will notify the funeral home once
everything is complete.

•

An order for release of the body needs to be entered into EPIC.

Finally, “thank you” for your compassion and sensitivity in the care of the deceased. Families always
remember those final moments and the caring manner of staff after death. It is a lasting impression
and a testimony of our mission and values.
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Anticoagulation Management Program Implementation
Debra Miller, Pharm.D., Medication Safety Pharmacist

The Joint Commission has introduced a new National Patient Safety Goal to reduce the likelihood of
patient harm from therapeutic anticoagulation with Heparin, Warfarin and Low Molecular Weight
Heparin. The program intent is to individualize anticoagulation therapy for each patient through use
of standardized evidence-based practices specifically designed to reduce the risk of adverse drug
events.
The goal includes the following eleven requirements, with the expectation that, as of January 1, 2009,
the process is fully implemented across the organization. Please review the following list of
policies/protocols that were updated to meet the new requirements:
1. The organization must implement a defined anticoagulant management program to
individualize the care provided to each patient receiving anticoagulant therapy. See:
•
•
•
•

Warfarin General Dosing and Reversal Guidelines
Warfarin Anticoagulation Ordering Policy
Heparin and Low Molecular Weight Heparin (LMWH) Including Enoxaparin (Lovenox)
Anticoagulation Ordering Policy
Anticoagulant Therapy: Management and Monitoring in the Home Setting

2. The organization uses approved protocols for the initiation and maintenance of anticoagulation
therapy appropriate to the medication used, to the condition being treated, and to the
potential for drug interactions. See:
•

Heparin Weight Based Protocol

•

St. Cloud Hospital Clinical Pharmacy Warfarin Dosing Service Protocol:
To order a pharmacist consult for dosing warfarin, prescribers should place a “Pharmacy to
Dose Warfarin Consult” in EPIC and state the desired INR goal range. Pharmacists use
evidence-based Warfarin General Dosing and Reversal Guidelines within a protocol that was
approved by the Pharmacy and Therapeutics Committee. Daily INR will be ordered by the
pharmacist per protocol (if not already ordered) for all inpatients. For patients in Inpatient
Rehab and Adult Mental Health who are stabilized on warfarin therapy, the frequency of INR
may be decreased to every 3 days. The physician will be contacted anytime the INR is greater
than 5.0 and/or signs of significant bleeding are reported, for reversal strategy.

•

Adult Renal Dosing Protocol (see Lovenox)

•

Anticoagulant Therapy: Heparin/Low Molecular Weight Heparin (LMWH), Coumadin Policy

•

Drug/Drug Interaction Policy

3. To reduce compounding and labeling errors, the organization uses ONLY oral unit dose
products and pre-mixed infusions, when these products are available.
•

Provided by Pharmacy

4. When pharmacy services are provided by the organization warfarin is dispensed for each
patient in accordance with established monitoring procedures. See:
•
•

St. Cloud Hospital Clinical Pharmacy Warfarin Dosing Service Protocol
Warfarin Anticoagulation Ordering Policy
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5. For patients being started on warfarin, a baseline International Normalized Ratio (INR) is
available, and for all patients receiving warfarin therapy, a current INR is available and is used
to monitor and adjust therapy. See:
•

Warfarin Anticoagulation Ordering Policy

6. When dietary services are provided by the organization, the service is notified of all patients
receiving warfarin and responds according to its established food/drug interaction program.
See:
•
•

Drug/Food Interaction Counseling Policy
Drug/Food Interaction Counseling, Appendix B, Identified Drugs:
Dietitians are automatically notified via the Epic of each initial warfarin order and do not
require the nurse to place a dietitian consult. Dietitians will complete food and drug
interaction education for all patients who are new to warfarin. Warfarin education consults DO
NOT automatically need to be placed by the nursing staff. However, for those patients
previously taking warfarin prior to admission that still have concerns related to warfarin and
Vitamin K intake, nursing may then place a dietitian consult as needed. Food Services is also
notified daily of all patients currently receiving warfarin for review of menu items for
appropriateness.

7. When heparin is administered intravenously and continuously, the organization uses
programmable infusion pumps. See:
•

Medication Administration Policy, High Alert Medications, Addendum B

8. The organization has a policy that addresses baseline and ongoing laboratory tests that are
required for heparin and low molecular weight heparin therapies.
•

Heparin and Low Molecular Weight Heparin (Lovenox) Anticoagulation Ordering Policy (new
policy):

•

The Pharmacy and Therapeutics Committee approved a new Heparin and Low Molecular Weight
Heparin (Lovenox) Anticoagulation Ordering Policy which may be viewed on Centranet. The
policy describes standards of practice and procedures for dosing and monitoring of
Heparin/LMWH that is similar to the Warfarin Anticoagulation Ordering Policy that was
approved in March. Some of this information is summarized here. Platelet monitoring is
suggested for patients receiving prophylactic subcutaneous heparin at baseline and every two
days on days 4-14 to monitor for heparin induced thrombocytopenia. For Lovenox, platelet
counts are suggested at baseline and every three days on days 4-14. When therapeutic
anticoagulation doses of Lovenox are used at 1 to 1.5 mg/kg in obese patients the maximum
dose will be capped at 150 mg/dose. Anti-Xa monitoring may be used to guide therapy and
pharmacists will consult physicians regarding ordering of these. For patients with renal
dysfunction at < 30 ml/min, a continuous infusion of Heparin should be used instead of
Lovenox.

9. The organization provides education regarding anticoagulation therapy to prescribers, staff,
patients, and families.
•

Nurses and Dieticians: Medication Safety – Anticoagulation and High Alert Medications
computerized module.

•

Pharmacists: Warfarin, Heparin, Lovenox and High Alert Drugs computerized module and SCH
Clinical Pharmacy Warfarin Dosing Service Competency Exam.
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•

Prescribers: “Anticoagulation Management Program” article in Medical Staff Update December
2008 issue, and “Warfarin General Dosing and Reversal Guidelines” pocket card available in
Medical Staff Office.

•

Patients/families: Every patient in the hospital is required to receive a standard approved
anticoagulation teaching sheet, even those patients who have had this education in the past
(see instructions on accessing these below).

10. Patient/family education includes the importance of follow-up monitoring, compliance issues,
dietary restrictions, and potential for adverse drug reactions and interactions.
Accessing SCH approved standard patient/family education:
•

Warfarin Education Sheet: St. Cloud Hospital has identified a standard teaching sheet for
warfarin, and it is available through Order Entry in Epic. The PMI/DFIs from Micromedex and
McKesson are not approved for patient education of warfarin. To print the teaching sheet
through Order Entry in Epic type: “Optio – Warfarin” in the search box. Select OPTIO-CMHC
COUMADIN (WARFARIN) EDUCATION SHEET. Review the education sheet with the patient and
document education teaching point into EPIC.

•

Enoxaparin (Lovenox) Teaching Kit: The standard patient education teaching sheet identified
for Lovenox is available through the Distribution Center. Order teaching kit through Order
Entry in Epic by typing “LOVENOX” in the search box, then select “KIT LOVENOX PATIENT
EDUCATION”. Review information with patient and document education teaching point into
Epic.

•

Heparin Education Sheet: The standard patient education teaching sheet identified for
heparin is available in MICROMEDEX CareNotesTM System. Print Heparin (injection) teaching
sheet, review with patient, and document education teaching point into EPIC.

Documentation of patient teaching into Epic (Warfarin Example):
Every patient in the hospital is required to receive an anticoagulation teaching sheet, even those
patients who have had this education in the past and the teaching point must be documented into
Epic:
1. Enter Patient Education activity.
2. Select “Add Point” from the Unresolved Education tab.
3. Search for “coumadin” and select COUMADIN POINT to add to unresolved education list.
11. The organization evaluates anticoagulation safety practices.
•

Oversight of this requirement is through Medication Safety, Pharmacy and Therapeutics,
Medical Care Review, and Advanced Nurse Practice – PI Committees.
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Warfarin General Dosing & Reversal Guidelines
DAY

INR

1

< 1.5

2

< 1.8

3

4

5

6

1.92.5

Warfarin Dose for <
80kg
5 mg (2.5 mg if age >
60)
5 mg (see previous
dose)
2.5-5 mg

Warfarin Dose for >
80kg
7.5 mg (5 mg if age >
60)
7.5 mg (see previous
dose)
2.5-5 mg

2.63.0

0-2.5 mg

0-2.5 mg

> 3.0

NONE

NONE

< 1.8
1.92.5

5 mg
2.5-5 mg

7.5 mg
2.5 mg

2.63.0
> 3.0

0-2.5 mg (see
previous dose)
NONE

0-2.5 mg (see previous
dose)
NONE

< 1.5
1.51.9

10 mg
5-7.5 mg

10-15 mg
5-10 mg

2.03.0
> 3.0

Maintain previous
dose
0-2.5 mg

Maintain previous
dose
0-2.5 mg

< 1.5
1.51.9

10 mg
7.5-10 mg

10-15 mg
5-10 mg

2.03.0
> 3.0

Maintain previous
dose
0-2.5 mg

Maintain previous
dose
0-2.5 mg

< 1.5
1.51.9

7.5-12.5 mg
5-10 mg

15 mg
5-12.5 mg

2.03.0

Maintain previous
dose
0-5 mg (depending
on previous dose)

Maintain previous
dose
0-5 mg (depending on
previous dose)

> 3.0

INR
Above
goal
range
but < 5.0
5.0 – 8.9

CLINICAL
PICTURE
No significant
bleeding

RECOMMENDATION
-Decrease dose or omit
warfarin dose and resume
when INR therapeutic

No significant
bleeding

-Omit warfarin x 1-2 doses OR--Omit warfarin dose and
give Vitamin K 1-2.5 mg PO

5.0 – 8.9

Rapid reversal
needed for surgery

-Omit warfarin -AND-Vitamin K 1-5 mg PO with
expectation for reduction in
INR in 24 hrs (may repeat 12
mg PO if needed)

> 9.0

No significant
bleeding

-Omit warfarin -AND-Vitamin K 2.5 -5 mg PO
(may repeat in 24 hrs if
needed)

Any
elevation
of INR

Serious bleeding

-Omit warfarin -AND-Vitamin K 10 mg slow IV
(may repeat q12 hrs if
needed) -May supplement
with fresh frozen plasma
(FFP), prothrombin complex
concentrates (PCC), or
recombinant factor VIIa
depending on the urgency of
the situation

Any
elevation
of INR

Life-threatening
bleeding

-Omit warfarin -AND--Fresh
frozen plasma (FFP),
prothrombin complex
concentrates (PCC), or
recombinant factor VIIa Supplement with vitamin K
10 mg slow IV (may repeat
q12 hrs if needed)

Chart is based on goal INR range of 2.0-3.0.
Charts adapted with permission from Mercy and Unity Hospital
Warfarin Dosing Service and from ACCP Evidence-Based Clinical
th
Practice Guidelines 8 Edn. CHEST. June 2008: 133(6Suppl):
160S-198S.
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~Clinical Ladder~

Congratulations to the following individuals for achieving
and/or maintaining their Level III Clinical Ladder status!
Ann Hess, RN
 Osteoporosis and You Class
 Dressing Change Audit
 Patient Education Committee
 EPIC Super User

Ortho/Neuro

Nancy Stiles, RN
Emergency Trauma Center
 Preceptor
 Clinical Ladder Secretary
 EBP: Sudden Death Notification
 Medication Safety Task Force
Carla Vanderpool, RN
Children’s Center
 Airway Cart Set-up
 Preceptor
 Easy IO Poster
 Patient Satisfaction Committee
Janelle Maciej, RN
Telemetry
 Upcoming Cardiac Medications Module
 Preceptor
 Biphasic Defibrillators Old/New Stations
 Clinical Ladder Committee
Amy Anderson, RN
Kidney Dialysis, Alexandria
 PI Committee, PI Audits
 Holistic Services DVD
 ANNA Education Committee Member
 Fistula First Committee
Cindy Emerson, RN
 Port Access Skill Station
 Patient Safety Monitoring Audit
 Peds Hem/Onc Advisory Board
 RNC, Pediatric
Nicole Witowski, RN
 Preceptor
 Instilling NS with Suctioning Poster
 Safeway Reporting Committee
 AACN-CMAC Secretary

Peds Short Stay

Angela Jordahl, RN
Kidney Dialysis
 PI Committee, PI Audits
 Fistula First Task Force
 Button-Hole Certification with Staff
 Research Study to Present Hypotension During
Dialysis
Gayle Howard, RN
 Med Safety Event
 Preceptor
 Total Joint Class Instructor
 ONC

Ortho/Neuro

Upcoming Developmental Programs:
Educational and Professional
February 2009
6

Basic Life Support Instructor Recertification
Course, Conference Center, 9 am-1 pm

9/10 Nursing Professional Development Cert.
Preparation Course, 7:30 am-4:30 pm,
Windfeldt Room, CentraCare Health Plaza
24

Sugar & Safe Care, Temp., Airway, Blood
Pressure, Lab Work, and Emotional Support
(STABLE), 7 am-5:30 pm, CentraCare Health
Plaza Education Center

26

10th Annual Cardiology Seminar, 7:30 am-4
pm, Windfeldt Room, Plaza

March 2009

PICU

Colleen Layne, RN
Center for Surgical Care
 Outpatient FHA
 PI Committee, PI Audits
 Chair, Engagement Task Force
 RNC, Med/Surg

2

Basic Life Support Instructor Initial
Course, Conference Center, 9 am-5 pm

24/25

Trauma Nursing Core Course (TNCC), 7:30
am-5:30 pm, SCH Conference Room

30/31

Emergency Nursing Pediatric Course/ENPC,
8 am-5:30 pm, SCH Conference Room

To find out what other educational and
professional developmental programs
are offered, please go to the CentraNet
Education Tab or call the Education
Department at Ext. 55642
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